Aggressive Approach in the Treatment of Acute Lead Encephalopathy With an Extraordinarily High Concentration of Lead
Robert Gordon(The University of Texas Health Science Center at Houston), Frank P. Paloucek(American Association of Colleges of Pharmacy), Zubair Amin(Khoo Teck Puat Hospital), Robert H. Williams(University of Washington)
Cited by 31
Related Papers
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
|Nature Medicine|2021|599
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction
|Circulation|2019|427
The HVAD Left Ventricular Assist Device
|JACC Heart Failure|2015|194